Related Experiment Video
Updated: Oct 16, 2025

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer
Darcie D Seachrist1,2, Lindsey J Anstine2,3, Ruth A Keri1,2,4,5
1Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Abstract:
The pioneering function of FOXA1 establishes estrogen-responsive transcriptomes in luminal breast cancer. Dysregulated FOXA1 chromatin occupancy through focal amplification, mutation, or cofactor recruitment modulates estrogen receptor (ER) transcriptional programs and drives endocrine-resistant disease. However, ER is not the sole nuclear receptor (NR) expressed in breast cancers, nor is it the only NR for which FOXA1 serves as a licensing factor. Receptors for androgens, glucocorticoids, and progesterone are also found in the majority of breast cancers, and their functions are also impacted by FOXA1. These NRs interface with ER transcriptional programs and, depending on their activation level, can reprogram FOXA1-ER cistromes. Thus, NR interplay contributes to endocrine therapy response and resistance and may provide a vulnerability for future therapeutic benefit in patients. Herein, we review what is known regarding FOXA1 regulation of NR function in breast cancer in the context of cell identity, endocrine resistance, and NR crosstalk in breast cancer progression and treatment.
Insights
FOXA1 regulates estrogen-responsive genes in breast cancer. Its interaction with other nuclear receptors influences endocrine therapy response and resistance, offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- FOXA1 is crucial for estrogen-responsive transcriptomes in luminal breast cancer.
- Dysregulated FOXA1 impacts estrogen receptor (ER) activity, driving endocrine resistance.
Purpose of the Study:
- To review FOXA1's regulation of nuclear receptor (NR) function in breast cancer.
- To explore NR interplay in endocrine resistance and therapeutic strategies.
Main Methods:
- Literature review of FOXA1's role in breast cancer.
- Analysis of NR crosstalk and its impact on ER transcriptional programs.
Main Results:
- FOXA1 regulates multiple NRs (androgen, glucocorticoid, progesterone) beyond ER.
- NRs reprogram FOXA1-ER cistromes, influencing endocrine therapy outcomes.
- NR interplay is key to endocrine therapy response and resistance.
Conclusions:
- FOXA1's multifaceted role in NR regulation impacts breast cancer progression.
- Understanding NR crosstalk offers therapeutic vulnerabilities for endocrine-resistant breast cancer.
More Related Videos
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
09:17Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Co-activators and Co-repressors
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
General Transcription Factors